These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
488 related items for PubMed ID: 12688833
1. Potentially significant drug interactions of class III antiarrhythmic drugs. Yamreudeewong W, DeBisschop M, Martin LG, Lower DL. Drug Saf; 2003; 26(6):421-38. PubMed ID: 12688833 [Abstract] [Full Text] [Related]
3. Pharmacologic and pharmacokinetic profile of class III antiarrhythmic drugs. Kowey PR, Marinchak RA, Rials SJ, Bharucha D. Am J Cardiol; 1997 Oct 23; 80(8A):16G-23G. PubMed ID: 9354408 [Abstract] [Full Text] [Related]
5. A benefit-risk assessment of class III antiarrhythmic agents. Brendorp B, Pedersen O, Torp-Pedersen C, Sahebzadah N, Køber L. Drug Saf; 2002 Oct 23; 25(12):847-65. PubMed ID: 12241126 [Abstract] [Full Text] [Related]
6. New advances in class III antiarrhythmic drug therapy. Sager PT. Curr Opin Cardiol; 1999 Jan 23; 14(1):15-23. PubMed ID: 9932203 [Abstract] [Full Text] [Related]
7. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents]. Scholz H. Z Kardiol; 1996 Jan 23; 85 Suppl 6():91-6. PubMed ID: 9064988 [Abstract] [Full Text] [Related]
8. New advances in class III antiarrhythmic drug therapy. Sager PT. Curr Opin Cardiol; 2000 Jan 23; 15(1):41-53. PubMed ID: 10666660 [Abstract] [Full Text] [Related]
9. [Antiarrhythmic therapy in patients with heart failure]. Faber TS, Zehender M. Ther Umsch; 2000 May 23; 57(5):324-32. PubMed ID: 10859993 [Abstract] [Full Text] [Related]
10. The coming of age of the class III antiarrhythmic principle: retrospective and future trends. Singh BN. Am J Cardiol; 1996 Aug 29; 78(4A):17-27. PubMed ID: 8780325 [Abstract] [Full Text] [Related]
11. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators. Bollmann A, Husser D, Cannom DS. Am J Cardiovasc Drugs; 2005 Aug 29; 5(6):371-8. PubMed ID: 16259525 [Abstract] [Full Text] [Related]
12. [New anti-arrhythmia agents]. Honerjäger P, Schmidt G. Z Kardiol; 1992 Aug 29; 81 Suppl 4():133-7. PubMed ID: 1363260 [Abstract] [Full Text] [Related]
13. Dofetilide, a novel class III antiarrhythmic agent. Rasmussen HS, Allen MJ, Blackburn KJ, Butrous GS, Dalrymple HW. J Cardiovasc Pharmacol; 1992 Aug 29; 20 Suppl 2():S96-105. PubMed ID: 1279316 [Abstract] [Full Text] [Related]
14. Initial experience with antiarrhythmic medication monitoring by clinical pharmacists in an outpatient setting: a retrospective review. Snider M, Kalbfleisch S, Carnes CA. Clin Ther; 2009 Jun 29; 31(6):1209-18. PubMed ID: 19695388 [Abstract] [Full Text] [Related]
15. Comparative effectiveness of antiarrhythmic drugs for rhythm control of atrial fibrillation. Qin D, Leef G, Alam MB, Rattan R, Munir MB, Patel D, Khattak F, Adelstein E, Jain SK, Saba S. J Cardiol; 2016 May 29; 67(5):471-6. PubMed ID: 26233885 [Abstract] [Full Text] [Related]
16. A benefit-risk assessment of class III antiarrhythmic agents. Elming H, Brendorp B, Pehrson S, Pedersen OD, Køber L, Torp-Petersen C. Expert Opin Drug Saf; 2004 Nov 29; 3(6):559-77. PubMed ID: 15500415 [Abstract] [Full Text] [Related]
17. Sotalol: a breakthrough antiarrhythmic? Nappi JM, McCollam PL. Ann Pharmacother; 1993 Nov 29; 27(11):1359-68. PubMed ID: 8286812 [Abstract] [Full Text] [Related]
18. Dofetilide, a new class III antiarrhythmic agent. Lenz TL, Hilleman DE. Pharmacotherapy; 2000 Jul 29; 20(7):776-86. PubMed ID: 10907968 [Abstract] [Full Text] [Related]
19. Interactions between implantable cardioverter-defibrillators and class III agents. Movsowitz C, Marchlinski FE. Am J Cardiol; 1998 Aug 20; 82(4A):41I-48I. PubMed ID: 9737653 [Abstract] [Full Text] [Related]
20. Class III antiarrhythmic drugs. Singh BN, Ahmed R. Curr Opin Cardiol; 1994 Jan 20; 9(1):12-22. PubMed ID: 8199363 [Abstract] [Full Text] [Related] Page: [Next] [New Search]